Pharmacology and Toxicology
Showing page 17 of 22 pages of list content
-
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
This article's authors -
Development of a highly sensitive bioanalytical assay for the quantification of favipiravir
This article's authors -
Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
This article's authors -
The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugs
This article's authors -
In vitroefficacy of Artemisia extracts against SARS-CoV-2
This article's authors -
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
This article's authors -
Induction of exaggerated cytokine production in human peripheral blood mononuclear cells by a recombinant SARS-CoV-2 spike glycoprotein S1 and its inhibition by dexamethasone
This article's authors -
Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture
This article's authors -
KLF2 is a therapeutic target for COVID-19 induced endothelial dysfunction
This article's authors -
Phospholipidosis is a shared mechanism underlying thein vitroantiviral activity of many repurposed drugs against SARS-CoV-2
This article's authors